Cargando…
A protocol of randomized controlled trial for Modified Xiaoyao Powder in the treatment of chronic obstructive pulmonary disease combined mild to moderate depression
INTRODUCTION: Depression is an important complication of chronic obstructive pulmonary disease (COPD), occurring in more than one-third of individuals with COPD, and its severity is closely related to the severity and acute exacerbation of COPD, significantly contributing to the risk of death from C...
Autores principales: | Chen, Keling, Zhao, Keni, Wang, Wujun, Xiao, Wei, Xiao, Jing, Yang, Yang, Liu, Yufei, Xie, Xiaohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676530/ https://www.ncbi.nlm.nih.gov/pubmed/33217836 http://dx.doi.org/10.1097/MD.0000000000023220 |
Ejemplares similares
-
A randomized controlled trial for the effect of Modified Shenling Baizhu Powder on delaying the illness progress of COPD stable phase patients (GOLD 1–2 stages): A study protocol
por: Liu, Yufei, et al.
Publicado: (2020) -
The relationship between levels of self-esteem and the development of depression in young adults with mild depressive symptoms
por: Choi, Yoobin, et al.
Publicado: (2019) -
Plasma metabolites were associated with spatial working memory in major depressive disorder
por: Du, Yue, et al.
Publicado: (2021) -
Assessment of post-traumatic stress disorder and health-related quality of life among patients recovered from mild-to-moderate COVID-19 and their close contacts: A cross-sectional study
por: Louis, Nageh, et al.
Publicado: (2023) -
Association between arginine catabolism and major depressive disorder: A protocol for the systematic review and meta-analysis of metabolic pathway
por: Cao, Bing, et al.
Publicado: (2020)